MTOR and cancer: It has been found that the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway is overstimulated in cancer cells that are resistant to chemotherapy, radiation, and hormone therapy [20].